Cargando…

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer

PURPOSE: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used for the diagnosis and staging of lung cancer. However, evidence of its usefulness for re-biopsy in treated lung cancer, especially according to the previous treatment, is limited. We evaluated the ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joohae, Kang, Hyo Jae, Moon, Sung Ho, Lee, Jong Mog, Kim, Hyae Young, Lee, Geon-Kook, Lee, Jin Soo, Hwangbo, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790847/
https://www.ncbi.nlm.nih.gov/pubmed/30913867
http://dx.doi.org/10.4143/crt.2019.031
_version_ 1783458853179883520
author Kim, Joohae
Kang, Hyo Jae
Moon, Sung Ho
Lee, Jong Mog
Kim, Hyae Young
Lee, Geon-Kook
Lee, Jin Soo
Hwangbo, Bin
author_facet Kim, Joohae
Kang, Hyo Jae
Moon, Sung Ho
Lee, Jong Mog
Kim, Hyae Young
Lee, Geon-Kook
Lee, Jin Soo
Hwangbo, Bin
author_sort Kim, Joohae
collection PubMed
description PURPOSE: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used for the diagnosis and staging of lung cancer. However, evidence of its usefulness for re-biopsy in treated lung cancer, especially according to the previous treatment, is limited. We evaluated the role of EBUS-TBNA for re-biopsy and its diagnostic values in patients with different treatment histories. MATERIALS AND METHODS: We reviewed the medical records of patients who underwent EBUS-TBNA for re-biopsy of suspicious recurrent or progressive lesions between January 2006 and December 2016 at the National Cancer Center in South Korea. Patients were categorized into three groups based on the previous treatment modalities: surgery, radiation, and palliation. RESULTS: Among the 367 patients (surgery, n=192; radiation, n=40; palliation, n=135) who underwent EBUS-TBNA for re-biopsy, the overall sensitivity, negative predictive value (NPV), and diagnostic accuracy of EBUS-TBNA in detecting malignancy were 95.6%, 82.7%, and 96.3%, respectively. The sensitivity was lower in the radiation group (83.3%) when compared with the surgery (95.7%, p=0.042) and palliation (97.7%, p=0.012) groups. The NPV was lower in the palliation group (50.0%) than in the surgery group (88.5%, p=0.042). The sample adequacy of EBUS-TBNA specimens was lower in the radiation group (80.3%) than in the surgery (95.4%, p < 0.001) or palliation (97.8%, p < 0.001) groups. EGFR mutation analysis was feasible in 94.6% of the 92 cases, in which mutation analysis was requested. There were no major complications. Minor complications were reported in 12 patients (3.3%). CONCLUSION: EBUS-TBNA showed high diagnostic values and high suitability for EGFR mutation analysis with regard to re-biopsy in patients with previously treated lung cancer. The sensitivity was lower in the radiation group and NPV was lower in the palliation group. The complication rate was low.
format Online
Article
Text
id pubmed-6790847
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-67908472019-10-21 Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer Kim, Joohae Kang, Hyo Jae Moon, Sung Ho Lee, Jong Mog Kim, Hyae Young Lee, Geon-Kook Lee, Jin Soo Hwangbo, Bin Cancer Res Treat Original Article PURPOSE: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used for the diagnosis and staging of lung cancer. However, evidence of its usefulness for re-biopsy in treated lung cancer, especially according to the previous treatment, is limited. We evaluated the role of EBUS-TBNA for re-biopsy and its diagnostic values in patients with different treatment histories. MATERIALS AND METHODS: We reviewed the medical records of patients who underwent EBUS-TBNA for re-biopsy of suspicious recurrent or progressive lesions between January 2006 and December 2016 at the National Cancer Center in South Korea. Patients were categorized into three groups based on the previous treatment modalities: surgery, radiation, and palliation. RESULTS: Among the 367 patients (surgery, n=192; radiation, n=40; palliation, n=135) who underwent EBUS-TBNA for re-biopsy, the overall sensitivity, negative predictive value (NPV), and diagnostic accuracy of EBUS-TBNA in detecting malignancy were 95.6%, 82.7%, and 96.3%, respectively. The sensitivity was lower in the radiation group (83.3%) when compared with the surgery (95.7%, p=0.042) and palliation (97.7%, p=0.012) groups. The NPV was lower in the palliation group (50.0%) than in the surgery group (88.5%, p=0.042). The sample adequacy of EBUS-TBNA specimens was lower in the radiation group (80.3%) than in the surgery (95.4%, p < 0.001) or palliation (97.8%, p < 0.001) groups. EGFR mutation analysis was feasible in 94.6% of the 92 cases, in which mutation analysis was requested. There were no major complications. Minor complications were reported in 12 patients (3.3%). CONCLUSION: EBUS-TBNA showed high diagnostic values and high suitability for EGFR mutation analysis with regard to re-biopsy in patients with previously treated lung cancer. The sensitivity was lower in the radiation group and NPV was lower in the palliation group. The complication rate was low. Korean Cancer Association 2019-10 2019-03-15 /pmc/articles/PMC6790847/ /pubmed/30913867 http://dx.doi.org/10.4143/crt.2019.031 Text en Copyright © 2019 by the Korean Cancer Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Joohae
Kang, Hyo Jae
Moon, Sung Ho
Lee, Jong Mog
Kim, Hyae Young
Lee, Geon-Kook
Lee, Jin Soo
Hwangbo, Bin
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
title Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
title_full Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
title_fullStr Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
title_full_unstemmed Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
title_short Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
title_sort endobronchial ultrasound-guided transbronchial needle aspiration for re-biopsy in previously treated lung cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790847/
https://www.ncbi.nlm.nih.gov/pubmed/30913867
http://dx.doi.org/10.4143/crt.2019.031
work_keys_str_mv AT kimjoohae endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer
AT kanghyojae endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer
AT moonsungho endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer
AT leejongmog endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer
AT kimhyaeyoung endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer
AT leegeonkook endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer
AT leejinsoo endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer
AT hwangbobin endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer